Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 23:13:1003919.
doi: 10.3389/fendo.2022.1003919. eCollection 2022.

Calreticulin and PDIA3, two markers of endoplasmic reticulum stress, are associated with metabolic alterations and insulin resistance in pediatric obesity: A pilot study

Affiliations

Calreticulin and PDIA3, two markers of endoplasmic reticulum stress, are associated with metabolic alterations and insulin resistance in pediatric obesity: A pilot study

Valentina Antoniotti et al. Front Endocrinol (Lausanne). .

Abstract

Our aim was to evaluate the markers of endoplasmic reticulum (ER) stress among children and adolescents with obesity in relation to metabolic alterations. Calreticulin (CALR) and PDIA3 circulating levels were assessed on 52 pediatric subjects-26 patients with obesity and 26 normal weight controls (4-18 years)-enrolled in a pilot study. Clinical and metabolic evaluations were performed (BMI-SDS, insulin, and glucose at fasting and during an oral glucose tolerance test, lipid profile, blood pressure), and metabolic syndrome was detected. PDIA3 was higher (p < 0.02) and CALR slightly higher in children with obesity than in controls. PDIA3 was related positively to the Tanner stages. Both PDIA3 and CALR were positively associated with insulin resistance, cholesterol, and triglycerides and the number of criteria identifying metabolic syndrome and negatively with fasting and post-challenge insulin sensitivity. Our preliminary findings suggest the existence of a link between ER stress and metabolic changes behind obesity complications even at the pediatric age. CALR and PDIA3 could be early markers of insulin resistance and dyslipidemia-related ER stress useful to stratify patients at high risk of further complications.

Keywords: ER stress; insulin; lipids; obesity; pediatrics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Some of the main mechanisms underlying the relationship between obesity, insulin resistance al URP-related chaperones activity. Nutrients intake, when is higher than cellular needs, causes an overproduction of unfolded proteins that require to be processed by ER. In these situations, ER activates multiple mechanisms to reduce stress sources. First, Insulin resistance is provoked by the cell to reduce the insulin-mediated protein transcription, lately being ad additional factor for the development of obesity. Secondly, ER activates UPR, increasing the activity of several enzymes such as caspases that are responsible of apoptotic processes in addition to ROS and inflammatory cytokines production. URP has also the role of increasing protein degradation (ERAD) and contemporarily of boosting folding capacity through oxidative protein folding, which is partially performed by the activation of the PDIA3/Calreticulin/Calnexin chaperones complex..

References

    1. Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism (2019) 92:6–10. doi: 10.1016/j.metabol.2018.09.005 - DOI - PubMed
    1. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab (2004) 89:2583–9. doi: 10.1210/jc.2004-0535 - DOI - PubMed
    1. Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, et al. . Trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet (2017) 390:2627–42. doi: 10.1016/S0140-6736(17)32129-3 - DOI - PMC - PubMed
    1. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. . Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med (2017) 377:13–27. doi: 10.1056/nejmoa1614362 - DOI - PMC - PubMed
    1. Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. . Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci (2019) 20:2358. doi: 10.3390/ijms20092358 - DOI - PMC - PubMed

Publication types